http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011039721-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38011bd5cfeee8cb61e5e4254e7ac656 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b7dc24880f062e343c81f875d0e1c80 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-142 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04 |
| filingDate | 2008-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d63dee14239c445f9e717eee76be4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df12931be9c3f066bf92ef040ccd38d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_756ea7bf2ecf0470547959a0c3d62ade http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f746c1ece2dd2173952cf107a703fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f6acd2f74aa21b161925246d5f5a9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9938f4648082e5208a50066076c65bff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2683a69145226c6c36df19644cbcf46 |
| publicationDate | 2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2011039721-A1 |
| titleOfInvention | Method for prediction about carcinogenicity of substance in rodent |
| abstract | Disclosed is a method for predicting about the carcinogenicity of a substance of interest in a rodent, which comprises the steps of: administering a solution of the substance to a test group and administering a solvent used in the solution to a control group; extracting mRNA from each of the test group and the control group, and measuring the expression level of mRNA for each of genes obtained by selecting at least one gene from (A) genes each comprising a nucleotide sequence depicted in any one of SEQ ID NOs: 1 to 5, (B) genes each comprising a nucleotide sequence depicted in any one of SEQ ID NOs: 6 to 8 and (C) genes each comprising a nucleotide sequence depicted in any one of SEQ ID NOs: 9 to 32; determining whether or not a significant difference in the level of mRNA expressed from the gene is observed between the test group and the control group; and determining that the substance has carcinogenicity when a significant difference in the level of the expression of mRNA from any one of the genes is observed between the test group and the control group and the direction of increase or decrease in the level of the expression of mRNA from any one of the genes is the same as the tendency which is previously defined for each gene. |
| priorityDate | 2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 313.